Blueprint Medicines Corp at Morgan Stanley Healthcare Conference Transcript
Good morning. And before we get going here, I have to give the requisite disclosures. Please note that all important disclosures including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk. I am David Lebowitz, one of the biotechnology analysts here, and I would like to welcome to the stage from Blueprint Medicines, CEO Jeff Albers. If you could just first, I guess, introduce yourself, talk about the company and its overall mission, that would be great.
Sure. So first off, on behalf of all the employees of Blueprint Medicines, I want to thank you, David, and Morgan Stanley team for including us in the conference. And would refer you to our securities filings our website as we'll be, I suspect, making
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |